Skip to main content Accessibility help
×
Home
Hostname: page-component-5959bf8d4d-2rjgt Total loading time: 0.287 Render date: 2022-12-09T14:08:37.192Z Has data issue: true Feature Flags: { "useRatesEcommerce": false } hasContentIssue true

Reducing patient radiation exposure during paediatric SVT ablations: use of CARTO® 3 in concert with “ALARA” principles profoundly lowers total dose

Published online by Cambridge University Press:  22 August 2014

Robert H. Pass*
Affiliation:
Pediatric Arrhythmia Service, Division of Pediatric Cardiology, Department of Pediatrics, Albert Einstein College of Medicine, The Children’s Hospital at Montefiore, Bronx, New York, United States of America
Gregory G. Gates
Affiliation:
Pediatric Arrhythmia Service, Division of Pediatric Cardiology, Department of Pediatrics, Albert Einstein College of Medicine, The Children’s Hospital at Montefiore, Bronx, New York, United States of America
Laura A. Gellis
Affiliation:
Pediatric Arrhythmia Service, Division of Pediatric Cardiology, Department of Pediatrics, Albert Einstein College of Medicine, The Children’s Hospital at Montefiore, Bronx, New York, United States of America
Lynn Nappo
Affiliation:
Pediatric Arrhythmia Service, Division of Pediatric Cardiology, Department of Pediatrics, Albert Einstein College of Medicine, The Children’s Hospital at Montefiore, Bronx, New York, United States of America
Scott R. Ceresnak
Affiliation:
Pediatric Arrhythmia Service, Division of Pediatric Cardiology, Department of Pediatrics, Albert Einstein College of Medicine, The Children’s Hospital at Montefiore, Bronx, New York, United States of America
*
Correspondence to: R. H. Pass, MD, Pediatric Arrhythmia Service, Division of Pediatric Cardiology, Department of Pediatrics, Albert Einstein College of Medicine, The Children’s Hospital at Montefiore, 3415 Bainbridge Avenue, R1 Bronx, NY 10467, United States of America. Tel: +718 741 2183; Fax: +718 654 3024; E-mail: Pediheart@aol.com

Abstract

Background: “ALARA – As Low As Reasonably Achievable” protocols reduce patient radiation dose. Addition of electroanatomical mapping may further reduce dose. Methods: From 6/11 to 4/12, a novel ALARA protocol was utilised for all patients undergoing supraventricular tachycardia ablation, including low frame rates (2–3 frames/second), low fluoro dose/frame (6–18 nGy/frame), and other techniques to reduce fluoroscopy (ALARA). From 6/12 to 3/13, use of CARTO® 3 (C3) with “fast anatomical mapping” (ALARA+C3) was added to the ALARA protocol. Intravascular echo was not utilised. Demographics, procedural, and radiation data were analysed and compared between the two protocols. Results: A total of 75 patients were included: 42 ALARA patients, and 33 ALARA+C3 patients. Patient demographics were similar between the two groups. The acute success rate in ALARA was 95%, and 100% in ALARA+C3; no catheterisation-related complications were observed. Procedural time was 125.7 minutes in the ALARA group versus 131.4 in ALARA+C3 (p=0.36). Radiation doses were significantly lower in the ALARA+C3 group with a mean air Kerma in ALARA+C3 of 13.1±28.3 mGy (SD) compared with 93.8±112 mGy in ALARA (p<0.001). Mean dose area product was 92.2±179 uGym2 in ALARA+C3 compared with 584±687 uGym2 in ALARA (p<0.001). Of the 33 subjects (42%) in the ALARA+C3 group, 14 received ⩽1 mGy exposure. The ALARA+C3 dosages are the lowest reported for a combined electroanatomical–fluoroscopy technique. Conclusions: Addition of CARTO® 3 to ALARA protocols markedly reduced radiation exposure to young people undergoing supraventricular tachycardia ablation while allowing for equivalent procedural efficacy and safety.

Type
Original Articles
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Van Hare, GF, Javitz, H, Carmelli, D, et al. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol 2004; 15: 759770.CrossRefGoogle ScholarPubMed
2. Tanel, RE, Walsh, EP, Triedman, JK, Epstein, MR, Bergau, DM, Saul, JP. Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients. J Pediatr 1997; 131: 878887.CrossRefGoogle ScholarPubMed
3. Mettler, FA Jr., Koenig, TR, Wagner, LK, Kelsey, CA. Radiation injuries after fluoroscopic procedures. Semin Ultrasound CT and MR 2002; 23: 428442.CrossRefGoogle ScholarPubMed
4. Venneri, L, Rossi, F, Botto, N, et al. Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: insights from the National Research Council’s Biological Effects of Ionizing Radiation VII Report. Am Heart J 2009; 157: 118124.CrossRefGoogle ScholarPubMed
5. Wagner, LK, Eifel, PJ, Geise, RA. Potential biological effects following high X-ray dose interventional procedures. J Vasc Interv Radiol 1994; 5: 7184.CrossRefGoogle Scholar
6. Clark, J, Bockoven, JR, Lane, J, Patel, CR, Smith, G. Use of three-dimensional catheter guidance and trans-esophageal echocardiography to eliminate fluoroscopy in catheter ablation of left-sided accessory pathways. Pacing Clin Electrophysiol 2008; 31: 283289.CrossRefGoogle ScholarPubMed
7. Gist, K, Tigges, C, Smith, G, Clark, J. Learning curve for zero-fluoroscopy catheter ablation of AVNRT: early versus late experience. Pacing Clin Electrophysiol 2011; 34: 264268.CrossRefGoogle ScholarPubMed
8. Miyake, CY, Mah, DY, Atallah, J, et al. Nonfluoroscopic imaging systems reduce radiation exposure in children undergoing ablation of supraventricular tachycardia. Heart Rhythm 2011; 8: 519525.CrossRefGoogle Scholar
9. Von Bergen, NH, Bansal, S, Gingerich, J, Law, IH. Nonfluoroscopic and radiation-limited ablation of ventricular arrhythmias in children and young adults: a case series. Pediatr Cardiol 2011; 32: 743747.CrossRefGoogle Scholar
10. Gellis, LA, Ceresnak, SR, Gates, GJ, Nappo, L, Pass, RH. Reducing patient radiation dosage during pediatric SVT ablations using an “ALARA” radiation reduction protocol in the modern fluoroscopic era. Pacing Clin Electrophysiol 2013; 36: 688694.CrossRefGoogle ScholarPubMed
11. Ubeda, C, Vano, E, Gonzalez, L, Miranda, P. Influence of the antiscatter grid on dose and image quality in pediatric interventional cardiology X-ray systems. Catheter Cardiovasc Interv 2013; 82: 5157.CrossRefGoogle Scholar
12. Partridge, J, McGahan, G, Causton, S, et al. Radiation dose reduction without compromise of image quality in cardiac angiography and intervention with the use of a flat panel detector without an antiscatter grid. Heart 2006; 92: 507510.CrossRefGoogle Scholar
20
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Reducing patient radiation exposure during paediatric SVT ablations: use of CARTO® 3 in concert with “ALARA” principles profoundly lowers total dose
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Reducing patient radiation exposure during paediatric SVT ablations: use of CARTO® 3 in concert with “ALARA” principles profoundly lowers total dose
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Reducing patient radiation exposure during paediatric SVT ablations: use of CARTO® 3 in concert with “ALARA” principles profoundly lowers total dose
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *